The aim of the present study was to deepen the understanding of the role of Notch signaling upregulation [36–40] in MM by investigating its cross talk with the chemokine IL-6, a key player of MM progression and severity [15–19]. The gene discussed is IL6; the disease is Miyoshi myopathy.